Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

NCT04247594 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Data will not inform further development of Voxelotor

Conditions

Interventions

Sponsor

Pfizer